Farther Finance Advisors’s Dianthus Therapeutics DNTH Stock Holding History

Farther Finance Advisors’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.75K	Buy	54 +18	+50%	+$1.87K	﹤0.01%	5036
2026 Q2	$3.51K	Buy	36 +2	+6%	+$175	﹤0.01%	4964
2026 Q1	$2.88K	Sell	34 -205	-86%	-$11.9K	﹤0.01%	4754
2025 Q4	$9.85K	Sell	239 -251	-51%	-$9.73K	﹤0.01%	3925
2025 Q3	$19.3K	Buy	+490	New	+$12.5K	﹤0.01%	3063

Other funds holding DNTH

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

GBT

Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's DNTH Position: Q3 2026 in Review

Farther Finance Advisors increased its Dianthus Therapeutics (DNTH) stake by 50% in Q3 2026, buying an estimated $1.87K and bringing the position to 54 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #5036.

Farther Finance Advisors first reported a position in DNTH in Q3 2025 and has held it in 5 quarters since. The position peaked at $19.3K in Q3 2025. 5 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

Farther Finance Advisors held 54 shares of Dianthus Therapeutics worth $4.75K as of Q3 2026.
Farther Finance Advisors bought 18 Dianthus Therapeutics shares in Q3 2026, an estimated $1.87K.
Dianthus Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5036 holding.
Farther Finance Advisors first reported a position in Dianthus Therapeutics in Q3 2025 and has held it in 5 quarters since.
Farther Finance Advisors's Dianthus Therapeutics position peaked at $19.3K in Q3 2025.
5 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.